Abbott Diabetes Care recalls FreeStyle lnsulinx Blood Glucose Meters
ALAMEDA, Calif. — Abbott Diabetes Care earlier this week initiated a voluntary recall of its FreeStyle lnsulinx Blood Glucose Meters in the United States.
"Our first priority is to safeguard the health and safety of patients," stated Heather Mason, SVP Diabetes Care, Abbott. "We are committed to ensuring that our customers are able to continue to test their blood glucose with confidence, and we initiated this voluntary recall to ensure our products continue to meet the highest standards of quality and safety."
The company has determined that at extremely high blood glucose levels of 1024 mg/dL and above, the FreeStyle lnsulinx Meter will display and store in memory an incorrect test result that is 1024 mg/dL below the measured result. For example, at a blood glucose value of 1066 mg/dL, the meter will display and store a value of 42 mg/dL.
No other Abbott blood glucose meters are impacted by this issue.
Blood glucose levels at 1024 mg/dL and above are very rare. However, if high blood glucose levels of 1024 mg/dL and above do occur, they are a serious health risk and require immediate medical attention. As the FreeStyle lnsulinx Meter can display an inaccurate low result at a blood glucose level above 1024 mg/dL, there may be a delay in the identification and treatment of severe hyperglycemia, or incorrect treatment may be given, the company noted.
The company is notifying all registered users, healthcare professionals, pharmacies and distributors where the FreeStyle lnsulinx Meter is sold. Abbott estimates that there are approximately 50,000 active FreeStyle lnsulinx Meter users in the United States.
Are you a nurse practitioner or physician’s assistant? Join our Facebook group to get all the latest news dedicated to delivering healthcare services to patients in retail pharmacy clinics.
Physician-authored article sees ‘freeing’ nurses as one answer to healthcare crisis
NEW YORK — “It’s time to unlock the gates to the primary care club” and allow nurse practitioners to practice to the full extent of their education and training. That was a key message of a physician-authored article that recently ran in Slate magazine.
“Nurse practitioners should be released from their arbitrary bondage and do what they are trained to do, what they’re board-certified to do, and what many do so well: take care of patients and collaborate with physicians because they want to, not because they have to. Nurse practitioners and doctors should welcome each other’s perspectives, experiences, and abilities,” wrote Anne Reisman in the article titled “Free the Nurses.” Reisman is a physician in Connecticut.
In the article, posted April 18, Reisman outlines why she believes the “time is ripe” for change. Not only is student interest in primary care on the down slope, but the strain on the U.S. healthcare system will be further exasperated when some 30 million Americans gain coverage through the Patient Protection and Affordable Care Act.
She also highlights research that shows "nurse practitioners provide as good care with as good outcomes as primary care physicians, along with high rates of patient satisfaction."
Given that Reisman is a physician, she also brings an interesting insight to the table — primary care is an “ever-evolving conglomeration of medical knowledge and systems and empathy and integrity and creativity in problem-solving, this is precisely why it’s good to mix it up and reap the benefits of some nurse practitioner-doctor hybrid vigor.”
To read the entire article click here.
Nearly one-third of women don’t fill new osteoporosis prescriptions, study finds
PASADENA, Calif. — A new study by Kaiser Permanente finds that a large percentage of women with osteoporosis fail to pick up new prescriptions for the condition.
The study, which was based on the electronic health records of 8,454 women ages 55 years and older who were Kaiser Permanente Southern California members between December 2009 and March 2011 and were prescribed a new bisphosphonate medication, found that 29.5% of them did not pick up their prescription within 60 days of the order date. The problem was particularly acute among older women and those who used the emergency department in the prior year, but women taking other prescription drugs and those who had been hospitalized in the prior year were more likely to pick up their prescription. The same was true of women who had received their prescription from a doctor practicing at Kaiser Permanente for 10 years or longer.
"Although bisphosphonates have been proven to reduce the risk of osteoporotic fracture, low adherence to these medications is common, which contributes to serious and costly health problems," Kaiser Permanente scientist and lead study author Kristi Reynolds said. "This study simultaneously examined patient and prescribing provider characteristics and helped identify certain factors associated with why patients failed to pick up their new prescriptions."
The study was published this week in the journal Osteoporosis International.